DeutschNewstral
Article
dailyherald.com on 2016-10-10 15:39
Lundbeck's Carnexiv gets FDA orphan drug status
Related news
SA biotech gets FDA orphan drug designationbizjournals.com- Annovis Bio seeks orphan drug status from FDA for its lead new drug candidatebizjournals.com
- MAstraZeneca: FDA gives orphan drug status to two liver cancer drugsmarketwatch.com
- Durham drug developer gets FDA cash to work on orphan disease drugbizjournals.com
FDA Finalizes Guidance On Interpretation Of Orphan Drug “Sameness” For Gene Therapy Productsjdsupra.com- Philadelphia gene therapy company gets FDA Orphan Drug Designation for lead product candidatebizjournals.com
LifeBond’s surgical sealant gets EU approval, FDA fast-track statustimesofisrael.com
LI-tested cancer drug gets early FDA approvalNewsday
Marijuana-based drug gets positive review from FDAKING 5
Drug for flagging female libido gets FDA hearingThe Columbian
Pfizer breast cancer drug gets early FDA approvalabc3340.com- Binge eating disorder drug made locally gets FDA approvalbizjournals.com
Alzheimer’s drug gets boost from FDA staff despite inconclusive noteSeattle Times
Marijuana-derived drug for epilepsy gets FDA committee recommendationCNN- FDA finalizes guidance on Orphan Drug “sameness” of gene therapiesjdsupra.com
Sapience Therapeutics ST-36 receives orphan drug designation from FDAwestfaironline.com- FDA pilot program could help Wave avoid orphan-drug pitfallsbizjournals.com
- MProQR shares rises on FDA orphan drug designationmarketwatch.com
- Ahead of split, Ironwood gets FDA fast track status for heart drugbizjournals.com
Vertex drug gets FDA approvalBoston Herald